ABSTRACT. Backgrounds. The instability of cardiac output (CO) measured by PulseCOä (LiDCO Ltd.) during cardiac surgery has been reported. In the present study, we investigated the effects of vasodilation by prostaglandin E1 (PGE1) on the relation between cardiac output measured by PulseCOä and that by thermodilution. Methods. Twenty patients who underwent off-pump coronary artery bypass grafting (OPCAB) were enrolled in this study. After premedication with oral diazepam 10 mg, anesthesia was induced with midazolam, fentanyl and vecuronium. CO was measured after anesthesia induction, at PGE1 0.01, 0.02 and 0.04 lg/(kg min) and at 15 min after the stop of the infusion. Results. Systemic vascular resistances (SVRs) by PGE1 at 0.02 and 0.04 lg/(kg min) were significantly lower than the control value. The correlation coefficient (R 2 ) between the two techniques at each point, percentage error and limits of agreement (bias ±2SD of bias) were 0.78, 3, 0.05 ± 0.17 at 0.01 lg/(kg min), 0.20, 10, )0.18 ± 0.12 at 0.02 lg/(kg min), 0.46, 28, )0.50 ± 0.24 at 0.04 lg/(kg min) and 0.97, 1, 0.02 ± 0.27 L/min at 15 min after stop of infusion, respectively. Conclusion. PulseCOä might underestimate CO compared to that by bolus thermodilution method when simply decreasing the SVR by infusion of PGE1. Therefore, PulseCOä might be unsuitable in cardiac surgery.
INTRODUCTION
To measure cardiac output (CO), thermodilution method has been usually used. However, thermodilution method could not calculate beat-by-beat CO. PulseCOä (LiD-CO Ltd., London, UK) is one of the continuous CO monitors to measure beat-by-beat CO using pulse power analysis. Pulse power analysis was defined as the method to determine CO from characteristics of the entire arterial pressure waveform [1] . However, the arterial pressure waveform measured in a peripheral artery consists of the interaction between the wave from peripheral artery and heartbeat. Therefore, the arterial pressure waveform often changes during surgery because the arterial compliance changes according to the changes in sympathetic activity, intravascular blood volume, body position and vasoactive drugs used, etc. [2] [3] [4] . In our previous study, we suggested that cardiac output measured by PulseCOä is overestimated in comparison with thermodilution method in patients undergoing off-pump coronary artery bypass grafting (OPCAB) [5] . However, we could not show its mechanism. We focused on the arterial compliance which might have some effects on the calculation of CO measured by PulseCOä. In the present study, therefore, we investigated the effects of vasodilation induced by prostaglandin E1 (PGE1) on CO measured by PulseCOä in comparison with CO measured by bolus thermodilution method.
METHODS
Twenty patients who underwent OPCAB were enrolled in this study after the approval from hospital's ethics committee and patients' written informed consent. Patients who suffered from aortic and mitral valve stenosis and regurgitation were excluded from the study. After premedication with oral diazepam 10 mg 1 h before anesthesia induction, anesthesia was induced with midazolam 0.15 mg/kg and fentanyl 10 lg/kg. Tracheal intubation was facilitated with vecuronium 0.15 mg/kg. Anesthesia was maintained with midazolam, fentanyl and vecuronium. After induction, radial artery catheter and pulmonary artery catheter (REF: 774HF75, Edwards Lifescience LLC, Irvine, CA, USA) with a 9 Fr introducer (Percutaneous Sheath Introducer Kit, ARROW INTERNATIONAL, Bernville, PA, USA) were inserted. No vasopressor drugs were used until coronary artery bypass grafting started. CO was measured after induction of anesthesia to calibrate the PulseCOä and, subsequently, 15 min after each step-by-step infusion of PGE1 0.01, 0.02 and 0.04 lg/(kg min) and after the stop of PGE1. All measurements were done before starting surgery. Heart rate, arterial blood pressure, central venous pressure and pulmonary artery pressure were measured by a conventionary used monitor (Life Scope 9ä, NIHON KOHDEN, Tokyo, Japan). PulseCOä was connected to the monitor to take into the arterial pressure waveform to calculate CO. PulseCOä was initially calibrated with the value of CO measured by thermodilution and no recalibration was performed during the study. CO by the thermodilution method was measured with the Vigilanceä (Edwards Lifesciences LLC, Irvine, CA, USA).
For the thermodilution method, CO was measured three times at each measurement by injection of 0.2 ml/kg saline under 5°C and the mean value was calculated. The injections were carried out by the same senior-anesthesiologist to reduce a bias, without considering the relationship between the timing of the injection and the respiratory cycle.
STATISTICAL ANALYSIS
Data are expressed as mean ± standard deviation (SD). Hemodynamic variables were analyzed by repeated measures analysis of variance with Bonferroni correction. Correlation between CO measured by PulseCOä and thermodilution was determined by the linear regression analysis. The percentage of error, the correlation coefficient and the Bland-Altman plot were used to compare the two methods [6] . The percentage of the error was calculated as 100 Â (2SD)/(mean cardiac output). A p-value <0.05 was considered to be statistically significant.
RESULTS
Patients were 11 male and 9 female, 68 ± 7 years old, 156 ± 10 cm in height and 61 ± 7 kg in weight. Systemic vascular resistance (SVR) at 0.02 lg/(kg min) and at 0.04 lg/(kg min) were significantly lower than the control value (Table 1 ). There were no good correlation between the two techniques at 0.01 lg/(kg min) (Figures 1, 2) . The percentage error were higher at 0.02 lg/(kg min) and at 0.04 lg/(kg min) than at 0.01 lg/(kg min) and at 15 min after the stop of infusion. The bias were lower at 0.02 lg/(kg min) and at 0.04 lg/(kg min) than at 0.01 lg/(kg min) and at 15 min after the stop of infusion. (Table 1 and Figure 1 ).
DISCUSSION
Although we had demonstrated in our previous study that PulseCOä might overestimate CO in patients undergoing OPCAB [5] , the present study showed the opposite results when SVR decreased significantly by infusion of PGE1 0.02 and 0.04 lg/(kg min). Therefore, PulseCOä might be unsuitable in cardiac surgery.
The method to determine CO from characteristics of the arterial pressure waveform was called 'pulse power analysis' [1] . However, the arterial pressure waveform would be composed of the cardiac contraction force, the aortic compliance, the aortic impedance and the systemic peripheral resistance. Everytime when each parameter changes, pulse power analysis require calibration. PulseCOä originally uses a lithium chloride indicator dilution technique to calibrate measurement [7, 8] . However, in the present study, PulseCOä was calibrated with CO measured by bolus thermodilution method using pulmonary artery catheter, because a lithium chloride is not available for this purpose in Japan and bolus thermodilution method is the current standard to measure CO [9] . Therefore, in the present study, CO measured after induction was the same between the two methods.
In PulseCOä algorithm, compliance correction equation; DV/Dbp = Cal Â 250e )kAEbp (V: volume (ml), bp: blood pressure (mmHg), Cal: calibration factor, k: a fixed number) was used to know a standardized volume waveform and to calculate CO [1] . CO could be calculated by integration of the equation. Calibration factor should change by an alteration of arterial compliance induced by changes of systemic blood volume, sympathetic nerve activity or vasoactive drug usage, etc. However, PulseCOä could not continuously measure the arterial compliance. The arterial compliance could be defined only at the calibration periods. In the present study, we could simply decrease SVR by PGE1 infusion without any surgical stimuli. SVR significantly decreased at 0.02 and 0.04 lg/(kg min). Although we could not know the PulseCOä algorithm in detail, calibration factor might be small, when vasodilation occurs by PGE1.
In addition, arterial pressure waveform was composed of a compression phase and an expansion phase in the left ventricle. Jones et al. [10] reported that wave intensity in an expansion phase which is defined as multiplying blood pressure by blood flow was reduced during vasodilation. Therefore, arterial blood pressure wave form did not change uniformly. Because of biphasic change in arterial blood pressure wave form by vasodilation, PulseCOä might miscalculate CO.
In the present study, we used PGE1 as a vasodilator. PGE 1 is a potent short-acting vasodilator [11, 12] . Plasma PGE1 concentration has its peak within 5 min after the start of infusion and recover to pre-infusion level about 2 min after its cessation [13] . Therefore, 15 min might be enough to observe the effects of each dose of PGE1.
SVR decreased dose-dependently by PGE1 infusion. Thermodilution method is still the most common technique to measure CO and reported that thermodilution method was interchangeable with CO measurement by a peri-aortic trans-time flow-probe [14] . CO by PulseCOä significantly lower than CO by bolus thermodilution method, but the percentage of error was 28% at PGE1 0.04 lg/(kg min). Critchley and Critchley [15] suggested that acceptance of a new technique to measure cardiac Table 1 Data are expressed as mean ± standard deviation (SD), *p < 0.05 vs. control (calibration), p < 0.05 vs. cardiac output by bolus thermodilution method, ( ): 95% comfidence interval. output should rely on limits of agreement of up to ±30%.
In the previous study, we had demonstrated that CO by PulseCOä could not interchangeable in comparison with CO by thermodilution method during OPCAB because of it's surgical stimuli, maneuver and hemodynamic instability [5] . In the present study, we measured CO without any surgical stimuli. Therefore, we could say that PulseCOä underestimate CO under infusion of PGE1 0.04 lg/(kg min) in comparison with bolus thermodilution method.
The limitation of the present study is that we use the baseline CO measured by thremodilution method because of the impossibility of carrying out a basal measurement using the lithium dilution technique in Japan. Therefore, a correction factor might be different from that calculated by lithium dilution technique and the subsequent PulseCOä trend could be different.
In conclusion, PulseCOä might underestimate CO when simply decreasing SVR by infusion of PGE1 in comparison with CO measured by bolus thermodilution method. Therefore, PulseCOä might be unsuitable in cardiac surgery. 
